Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: Follow-up study

British Medical Journal

Volumn 332, Issue 7543, 2006, Pages 689-691

  Zackrisson, Sophia ^a   Andersson, Ingvar ^b   Janzon, Lars ^a   Manjer, Jonas ^a   Garne, Jens Peter ^c  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SCREENING; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; AGE; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC ERROR; INCIDENCE; MASS SCREENING; MIDDLE AGED; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; STANDARD; STATISTICS; SWEDEN;

AGE FACTORS; AGED; BREAST NEOPLASMS; DIAGNOSTIC ERRORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; SWEDEN;

EID: 33645513485     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38764.572569.7C     Document Type: Article

References (16)

1. Baines CJ. Are there downsides to mammography screening? Breast J 2005;11:87-10.
2. Duffy SW. Some current issues in breast cancer screening. J Med Screen 2005;12:128-33.
3. Day NE. Overdiagnosis and breast cancer screening. Breast Cancer Res 2005;7:228-9.
4. Paci E, Warwick J, Falini P, Duffy SW Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern? J Med Screen 2004;11:23-7.
5. Olsen AH, Jensen A, Njor SH, Villadsen E, Schwartz W, Vejborg I, et al. Breast cancer incidence after the start of mammography screening in Denmark. Br J Cancer 2003;88:362-5.
6. Zahl PH, Strand BH, Maehlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 2004;328:921-4.
7. Jonsson H, Johansson R, Lenner P. Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int J Cancer 2005;117:842-7.
8. Andersson I, Aspegren K, Janzon L, Landberg T, Lindhohn K, Linell F, et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 1988;297:943-8.
9. Peeters PH, Verbeek AL, Straatman H, Holland R, Hendriks JH, Mravunac M, et al. Evaluation of overdiagnosis of breast cancer in screening with mammography: results of die Nijmegen programme. Int J Epidemiol 1989;18:295-9.
10. Duffy SW, Agbaje O, Tabár L, Vitak B, Bjurstam N, Bjorneld L, et al. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res 2005;7:258-65.
11. Shapiro S, Goldberg JD, Hutchison GB. Lead time in breast cancer detection and implications for periodicity of screening. Am J Epidemiol 1974;100:357-66.
12. Moskowitz M. Breast cancer: age-specific growth rates and screening strategies. Radiology 1986;161:37-41.
13. Møller B, Weedon-Fekjaer H, Hakulinen T, Tryggvadottir L, Storm HH, Talbäck M, et al. The influence of mammographic screening on national trends in breast cancer incidence. Eur J Cancer Preu 2005;14:117-28.
14. Moss S. Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res 2005;7:230-4.
15. Matson S, Andersson I, Berglund G, Janzon L, Manjer J. Non-attendance in mammographic screening. A study of intra-urban differences from the city of Malmö in Sweden 1990-94. Cancer Detect Prev 2001;25:132-7.
16. Zackrisson S, Andersson I, Manjer J, Janzon L. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Int J Cancer 2004;108:754-60.